Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V - HSA Drug Approval Details

Approvals/HSA/LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V

Approved

THERAPEUTIC

LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V

Nitto Medic Co., Ltd.🇸🇬 Health Sciences Authority

Approval Date: Feb 18, 2020
Approval ID: d251560ec854ba89
Company: Nitto Medic Co., Ltd.
Type: Therapeutic

Approval Details

Approval Id: d251560ec854ba89
Drug Name: LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V
Product Name: LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V
Approval Number: SIN15884P
Approval Date: 2020-02-18
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: SOLUTION, STERILE
Route Of Administration: OPHTHALMIC
Atc Code: S01EE01
Atc Item Name: latanoprost
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/5b518d6208e83e06/pharmaforte-singapore-pte-ltd

Active Ingredients

Latanoprost

0.005% w/v

LATANOPROST

0.005% W/V

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 18, 2020

Approval ID

d251560ec854ba89

Type

Therapeutic

Back to HSA Approvals